Evaluation of a Primary Type 2 Diabetes Prevention Programme (PREDIAS)

August 8, 2014 updated by: Norbert Hermanns, Forschungsinstitut der Diabetes Akademie Mergentheim

Evaluation of a Teaching and Treatment Programme for Primary Prevention of Type 2 Diabetes

A type 2 diabetes prevention programme, named PREDIAS was developed. It consists of 12 lessons delivered as group sessions. Die efficacy of PREDIAS was studied in a randomized controlled study with 12 month follow up. Control group received written information about diabetes risk. Primary outcome variable was weight reduction at 12 months follow up. Secondary variables were impact of the intervention on glycemic parameters, lipids, eating and exercise behavior and other metabolic risk factors

Study Overview

Status

Completed

Conditions

Detailed Description

The PREDIAS programme was developed based on the interventions used in the Diabetes Prevention Study (DPS, Finland) and the Diabetes Prevention Programme (DPP; USA). The main purpose of PREDIAS was to develop a prevention programme delivered as a group programme to improve cost-benefit ration of diabetes prevention programmes.

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bad Mergentheim, Germany, D-97980
        • Research Institute of the Diabetes Academy Mergentheim (FIDAM)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • impaired fasting glucose and/or
  • impaired glucose tolerance
  • overweight (BMI > 26 kg/m²)

Exclusion Criteria:

  • type 2 diabetes
  • severe illness (cancer diagnosis, stroke or myocardial infarction in the last 12 months)
  • diagnosis of a current mental disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: 1/Control
Control group received written information about diabetes risks with instructions about healthy eating and increasing physical exercise
Written Information about diabetes risks. Brochure about the value of a healthy lifestyle, calorie table, suggestions for healthy food and daily exercise
EXPERIMENTAL: 2/PREDIAS
Intervention consists of a group programme (PREDIAS) aiming at modification of lifestyle
Group programme aiming at modification of lifestyle: lifestyle changes, 12 lesson a 90 minutes, delivered in a group setting, consists of analysis of barriers against lifestyle changes, behavior analysis of eating and exercise behavior, modification of unhealthy lifestyle and relapse prevention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Change
Time Frame: 12 month
Mean weight change (in kg) after 12 months
12 month
Waist Circumference
Time Frame: 12 months
Mean change in waist circumference (in cm) after 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting Glucose
Time Frame: 12 months
Mean changes in fasting glucose (in mg/dl) after 12 month
12 months
Glucose Tolerance
Time Frame: 12 months
Mean change in 2 hour postprandial oral glucose tolerance test (oGTT) (in mg/dl) after 12 months
12 months
Physical Exercise
Time Frame: 12 months
Mean changes in physical exercise (in min/week) after 12 months
12 months
Eating Behavior (TFEQ) - Cognitive Restraint
Time Frame: 12 months

The Three-Factor Eating Questionnaire (TFEQ) is a questionnaire used to assess food intake-behavior related research. The three factors of the TFEQ are: dietary restraint, disinhibition and hunger. The TFEQ contains 51 dichotomous Items (apply/ doesn't apply). The subscale "cognitive restraint" consists of 21 Item with a minimum score of "0" and a maximum score of "21". Low scores indicate an uninhibited eating behavior.

Mean change in the TFEQ - cognitive restraint scale after 12 months

12 months
Eating Behavior (TFEQ) - Disinhibition
Time Frame: 12 months

The Three-Factor Eating Questionnaire (TFEQ) is a questionnaire used to assess food intake-behavior related research. The three factors of the TFEQ are: dietary restraint, disinhibition and hunger. The TFEQ contains 51 dichotomous Items (apply/ doesn't apply). The subscale "disinhibition" consists of 16 Item with a minimum score of "0" and a maximum score of "16". High scores indicate an uninhibited eating behavior strongly depending on external cues.

Mean change in the TFEQ - disinhibition scale after 12 months

12 months
Eating Behavior (TFEQ) - Hunger
Time Frame: 12 months

The Three-Factor Eating Questionnaire (TFEQ) is a questionnaire used to assess food intake-behavior related research. The three factors of the TFEQ are: dietary restraint, disinhibition and hunger. The TFEQ contains 51 dichotomous Items (apply/ doesn't apply). The subscale "hunger" consists of 14 Item with a minimum score of "0" and a maximum score of "14". Low scores indicate an eating behavior strongly depending on feelings of hunger.

Mean change in the TFEQ - hunger scale after 12 months

12 months
Psychological Well-being (WHO-5)
Time Frame: 12 months

The WHO (Five) Well-being index consists of 5 items on the overall well-being over the last two weeks. Each of the five items is rated from 0 (= not present) to 5 (= constantly present). Scores are summated, with raw score ranging from 0 to 25. Then the scores are transformed to 0-100 by multiplying by 4, with higher scores meaning better well-being.

Mean change in psychological well-being score (WHO-5) after 12 months

12 months
Emotional Well-being/ Depression (CES-D)
Time Frame: 12 months

The Center for Epidemiologic Studies Depression Scale (CES-D) consists of 20 items scored from "0" to "3". Scores are summated, with raw score ranging from 0 to 25. Higher Scores idicate a higher depressive state.

Mean change in depression score (CES-D) after 12 months

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2004

Primary Completion (ACTUAL)

December 1, 2005

Study Completion (ACTUAL)

May 1, 2008

Study Registration Dates

First Submitted

June 26, 2008

First Submitted That Met QC Criteria

June 27, 2008

First Posted (ESTIMATE)

June 30, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

August 25, 2014

Last Update Submitted That Met QC Criteria

August 8, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe